• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IXC
Click for more information
0.00% 7.6¢

INVEX THERAPEUTICS LTD - Charts / Financials

Market Cap $5.636M  ! watchlist Created with Sketch. Add to my watchlist

Invex Therapeutics Ltd is an Australia-based biopharmaceutical company. The Company is... Invex Therapeutics Ltd is an Australia-based biopharmaceutical company. The Company is focused on developing treatments for neurological conditions and focused on developing treatments for neurological conditions. Its primary focus is Idiopathic Intracranial Hypertension (IIH), a condition of predominately overweight women of childbearing age, which can lead to disabling headaches and, in some patients, permanent vision loss. It has completed a Phase II trial. The Company’s lead program is the development of Presendin for IIH. Presendin is a once-per week, subcutaneous, sustained-release (SR) Exenatide microsphere formulation developed by Peptron, Inc. The Company is conducting a Phase III clinical trial (IIH EVOLVE) designed to meet the requirements for market approval of Presendin for the treatment of IIH in the European Union (EU), United Kingdom (UK) and Australia. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Last update - 16.20pm 21/11/2024 (20 minute delay) ?
Day
Open 7.6¢   Day High 7.6¢   Day Low 7.6¢
Daily Volume 17290
Bids   Sellers
Number Price Volume   Number Price Volume
1 6.7¢ 62461   1 8.2¢ 5490

Directors & Senior Management

Ms. Narelle Warren Chief Financial Officer, Company Secretary
Ms. Carol Parish Chief Operating Officer
Dr. Thomas Duthy Executive Director
Mr. David Mcauliffe Interim Non-Executive Chairman of the Board
Mr. David Colin Wheeler Non-Executive Director

Data source: Refinitiv

(20min delay)
Last
7.6¢ 		Change
0.000(0.00%) 		Mkt cap ! $5.636M
Open High Low Value Volume
7.6¢ 7.6¢ 7.6¢ $1.314K 17.29K

Buyers (Bids)

No. Vol. Price($)
1 62461 6.7¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 5490 1
View Market Depth
Last trade - 13.27pm 21/11/2024 (20 minute delay) ?

Top Stories

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
Alcidion inks deal with Vic health provider Peninsula for use of Miya Precision tech Alcidion Group Ltd has signed a contract worth $3.7M to enable use of its Miya Precision platform by users of Peninsula Health entities
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.